GLP-1 receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed for type 2 diabetes and weight management in the UK
Its indicated for those who have either of the following: a BMI of 27 kg/m2 or higher and at least one weight-related condition, such as high blood pressure a BMI of 30 kg/m2 or higher Keep in mind that semaglutide for weight loss is often combined with other interventions, like exercise and nutritional counseling
It improves insulin sensitivity, modestly reduces appetite, and produces a small amount of weight loss (typically 2 to 5 percent of body weight)
A structure-based assignment of the glutathione activator site without transition-state analogues is much more difficult because of labile GSH interactions 2 that likely depend not only on the presence of the first glutathione moiety but also on conformational changes of the glutathionylated enzyme 3,12,37,44
Whether these effects add together, overlap, or interfere when the compounds are combined has not been characterized
PMID 11792840